Clinical study on the diagnosis of liver metastasis in patients with pancreatic cancer by comprehensive blood biochemical indexes

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200066901

Enrollment

Unknown

Registered

2022-12-21

Start date

2022-12-30

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

Liver metastasis group:Not Applicable

No liver metastasis group:Not Applicable

Eligibility

Sex/Gender

All

Age

10 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients with pancreatic cancer: I. At first diagnosis, liver metastases are found; II, no liver metastases were found at initial diagnosis, and follow-up was longer than 6 months.

Exclusion criteria

Exclusion criteria: ?. The nature of intrahepatic lesions is not clear. ?. Lack of follow-up data.

Design outcomes

Primary

Measure	Time frame
Pulmonary imaging;liver function;Tumor Marker;	—

Countries

China

Contacts

Public ContactJiangfa Li

Affiliated Hospital of Guilin Medical University

247546160@qq.com07732824373

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026